SIGNIFICANCE OF THE ABCG2 Val12Met POLYMORPHISM IN CORONARY ARTERY DISEASE
<p>Objective. To assess the distribution of ABCG2 Val12Met alleles and genotypes in patients with coronary artery disease (CAD) and determine their association with CAD and hyperuricemia. The study included 197 participants: 102 patients with CAD and 95 apparently healthy controls. The Met allele was detected in 18.6% of patients versus 4.7% of controls and was associated with 4.6-fold higher odds of CAD (OR=4.6; 95%CI:2.28–9.31). The Val/Met genotype occurred in 31.4% and 9.5%, respectively (OR=4.4; 95%CI:2.04–9.38). Among CAD patients, Val/Met was present in 40.0% of subjects with hyperuricemia versus 19.0% of those with normal uric acid levels (OR=2.8; 95%CI:1.12–7.16). ABCG2 Val12Met may therefore represent a potential molecular genetic marker of cardiometabolic risk.</p>
Сведения
- Опубликовано
- 2026 · Т. 14, № 3, С. 976-981
- Язык
- Английский
- ISSN
- 2992-8958
- Издатель
- Nashr Matbaa Uyi MCHJ